Therapy for Depression With Co-Occurring Panic or Anxiety Symptoms
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This 6-month study, with a 3-month follow up period, will compare the effectiveness of new and traditional psychotherapies for depression with panic or anxiety symptoms.
| Condition | Intervention | Phase |
|---|---|---|
|
Depression Anxiety Disorders Panic Disorder |
Behavioral: Interpersonal Psychotherapy (IPT) Behavioral: IPT for Depression with Co-occurring Panic and Anxiety Symptoms (IPT-PS) |
Phase 1 Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Interpersonal Psychotherapy for Depression With Co-Occurring Panic and Anxiety Symptoms (IPT-PS) |
| Estimated Enrollment: | 36 |
| Study Start Date: | November 2002 |
| Study Completion Date: | August 2005 |
Many depressed patients also experience significant symptoms of panic or anxiety. This study will compare the effectiveness of a new therapy called interpersonal psychotherapy for depression with panic or anxiety symptoms (IPT-PS) with that of traditional interpersonal psychotherapy for depression (IPT).
Participants are randomly assigned to receive up to 24 weeks of treatment with either IPT-PS or traditional IPT. Improvements in interpersonal functioning, quality of life, and symptoms of depression and anxiety will be assessed at the end of therapy and at a 3-month follow-up.
Eligibility| Ages Eligible for Study: | 18 Years to 60 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- DSM-IV diagnosis of major depression with co-existing panic or anxiety symptoms.
Exclusion Criteria:
- History of manic episode(s). Patients who have had hypomanic episodes in the past will be accepted into the study, provided they meet other admission criteria and are not presenting in a current hypomanic or mixed episode.
- History of schizophrenia or schizoaffective disorder.
- Organic affective syndrome.
- Unspecified functional psychosis.
- Anorexia nervosa or bulimia nervosa. Patients meeting criteria for an eating disorder not otherwise specified will not be excluded.
- Chronic drug or alcohol abuse/dependence within the past 2 years. Patients with abuse related to episodes will not be excluded.
- DSM-IV criteria for borderline or antisocial personality disorder. Patients who meet criteria for other Axis II disorders will not be excluded.
- Inpatient treatment due to suicide risk or psychotic symptoms.
- Index episode secondary to the effect of medically prescribed drugs.
- Significant or untreated medical illness, including cardiovascular disorder, renal or liver disease, epilepsy, untreated hypertension, or unstabilized endocrine disease.
- Medical illness that would interfere with the best treatment strategy for the potential participant.
- Current treatment with an antidepressant. Patients on a stable dose of anxiolytics for at least 3 months prior to study participation who are able to maintain this dosage throughout the study will not be excluded.
- Pregnant and breast-feeding women will be accepted into the study, but will not be prescribed adjunctive medications.
Contacts and Locations
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00051207 History of Changes |
| Other Study ID Numbers: | R21 MH61948, DSIR AT-AS |
| Study First Received: | January 7, 2003 |
| Last Updated: | December 12, 2007 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institute of Mental Health (NIMH):
|
Mood Disorders Psychotherapy Comorbidity |
Additional relevant MeSH terms:
|
Anxiety Disorders Depression Depressive Disorder Panic Disorder |
Mental Disorders Behavioral Symptoms Mood Disorders |
ClinicalTrials.gov processed this record on May 22, 2013